Kevin O Leslie1. 1. Department of Laboratory Medicineand Pathology, Mayo Clinic Arizona, 13400 East Shea Blvd, Scottsdale, AZ 85259, USA. Leslie.Kevin@mayo.edu
Abstract
CONTEXT: Idiopathic pulmonary fibrosis is a progressive, fatal lung disease occurring in older individuals. Despite 50 years of accrued data about the disease, little progress has been made in slowing functional loss or in decreasing patient mortality. OBJECTIVE: To present a novel hypothesis on the etiology and pathogenesis of idiopathic pulmonary fibrosis. DESIGN: Published data are reviewed regarding the epidemiology, clinical presentation, natural history, radiologic findings, and pathologic findings in patients with idiopathic pulmonary fibrosis. RESULTS: Patients with idiopathic pulmonary fibrosis may be predisposed genetically to tractional injury to the peripheral lung. The result is recurrent damage to the epithelial-mesenchymal interface, preferentially at the outer edges of the basilar lung lobules where tractional stress is high during inspiration, compliance is relatively low, and there is a greater tendency for alveolar collapse at end-expiration. A distinctive "reticular network of injury" (the fibroblast focus) forms, attended by a prolonged phase of wound repair (tear and slow repair). Discrete areas of alveolar collapse are observed in scar at the periphery of the lung lobules. The cycle repeats over many years resulting in progressive fibrous remodeling and replacement of the alveoli in a lobule by bronchiolar cysts surrounded by scar (honeycomb lung). Abnormalities in surfactant function are proposed as a potential mechanism of initial lung damage. Age of onset may be a function of a required threshold of environmental exposures (eg, cigarette smoking) or other comorbid injury to the aging lung. CONCLUSIONS: Evidence supporting this hypothesis is presented and potential mechanisms are discussed. A potential role for contributing cofactors is presented.
CONTEXT: Idiopathic pulmonary fibrosis is a progressive, fatal lung disease occurring in older individuals. Despite 50 years of accrued data about the disease, little progress has been made in slowing functional loss or in decreasing patient mortality. OBJECTIVE: To present a novel hypothesis on the etiology and pathogenesis of idiopathic pulmonary fibrosis. DESIGN: Published data are reviewed regarding the epidemiology, clinical presentation, natural history, radiologic findings, and pathologic findings in patients with idiopathic pulmonary fibrosis. RESULTS:Patients with idiopathic pulmonary fibrosis may be predisposed genetically to tractional injury to the peripheral lung. The result is recurrent damage to the epithelial-mesenchymal interface, preferentially at the outer edges of the basilar lung lobules where tractional stress is high during inspiration, compliance is relatively low, and there is a greater tendency for alveolar collapse at end-expiration. A distinctive "reticular network of injury" (the fibroblast focus) forms, attended by a prolonged phase of wound repair (tear and slow repair). Discrete areas of alveolar collapse are observed in scar at the periphery of the lung lobules. The cycle repeats over many years resulting in progressive fibrous remodeling and replacement of the alveoli in a lobule by bronchiolar cysts surrounded by scar (honeycomb lung). Abnormalities in surfactant function are proposed as a potential mechanism of initial lung damage. Age of onset may be a function of a required threshold of environmental exposures (eg, cigarette smoking) or other comorbid injury to the aging lung. CONCLUSIONS: Evidence supporting this hypothesis is presented and potential mechanisms are discussed. A potential role for contributing cofactors is presented.
Authors: Sydney B Montesi; Rohan Rao; Lloyd L Liang; Hannah E Goulart; Amita Sharma; Subba R Digumarthy; Barry S Shea; Ravi T Seethamraju; Peter Caravan; Andrew M Tager Journal: Eur Respir J Date: 2018-05-17 Impact factor: 16.671
Authors: Richard K Albert; Bradford Smith; Carrie E Perlman; David A Schwartz Journal: Am J Respir Crit Care Med Date: 2019-07-15 Impact factor: 21.405
Authors: Matthias Ochs; Lars Knudsen; Jan Hegermann; Christoph Wrede; Roman Grothausmann; Christian Mühlfeld Journal: Histochem Cell Biol Date: 2016-09-29 Impact factor: 4.304
Authors: Heming Wang; Brian E Cade; Han Chen; Kevin J Gleason; Richa Saxena; Tao Feng; Emma K Larkin; Ramachandran S Vasan; Honghuang Lin; Sanjay R Patel; Russell P Tracy; Yongmei Liu; Daniel J Gottlieb; Jennifer E Below; Craig L Hanis; Lauren E Petty; Shamil R Sunyaev; Alexis C Frazier-Wood; Jerome I Rotter; Wendy Post; Xihong Lin; Susan Redline; Xiaofeng Zhu Journal: Hum Mol Genet Date: 2016-12-01 Impact factor: 6.150
Authors: Francisco Paulin; Tracy J Doyle; Elaine A Fletcher; Dana P Ascherman; Ivan O Rosas Journal: Rev Invest Clin Date: 2015 Sep-Oct Impact factor: 1.451
Authors: Nevins W Todd; Jeffrey R Galvin; Ashutosh Sachdeva; Irina G Luzina; Sergei P Atamas; Allen P Burke Journal: J Heart Lung Transplant Date: 2016-07-27 Impact factor: 10.247
Authors: Joshua K Park; Nathan J Coffey; Steven P Bodine; Charles N Zawatsky; Lindsey Jay; William A Gahl; George Kunos; Bernadette R Gochuico; May Christine V Malicdan; Resat Cinar Journal: Am J Respir Cell Mol Biol Date: 2020-02 Impact factor: 6.914
Authors: Daryle J DePianto; Sanjay Chandriani; Alexander R Abbas; Guiquan Jia; Elsa N N'Diaye; Patrick Caplazi; Steven E Kauder; Sabyasachi Biswas; Satyajit K Karnik; Connie Ha; Zora Modrusan; Michael A Matthay; Jasleen Kukreja; Harold R Collard; Jackson G Egen; Paul J Wolters; Joseph R Arron Journal: Thorax Date: 2014-09-12 Impact factor: 9.139
Authors: Eun Joo Chung; Grace McKay-Corkum; Su Chung; Ayla White; Bradley T Scroggins; James B Mitchell; Mary Jo Mulligan-Kehoe; Deborah Citrin Journal: Int J Radiat Oncol Biol Phys Date: 2015-12-14 Impact factor: 7.038